Monday, 12 Apr 2021

Medications

Pletal

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PLETAL® Cilostazol (sil-OS-tah-zol) Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you start using PLETAL. This leaflet answers some common questions about PLETAL. It does not contain all the available information.It does not take the place […]

APO-Tibolone

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-TIBOLONE tibolone Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines […]

Orgalutran

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ORGALUTRAN® Ganirelix (as acetate) 250 micrograms in 0.5 millilitres Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Orgalutran. It does not contain all the available information.It does not take the place of talking to your […]

Xermelo

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. XERMELO® This medicine is subject to additional monitoring. This will allow quick identificationof new safety information. You can help by reporting any side effects you may get.You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.   telotristat ethyl Consumer […]

Cerdelga

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CERDELGA® eliglustat Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Cerdelga. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have […]

Amira 150 and Amira 300

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AMIRA 150 AND AMIRA 300 moclobemide CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about AMIRA 150 and AMIRA 300 tablets. It does not contain all the available information.It does not take the place of talking […]

Oxytrol

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OXYTROL® CONSUMER MEDICINE INFORMATION V1.0 Oxybutynin (Ox-y-BEWT-ee-nin) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about the OXYTROL® transdermal drug delivery system (patch). It does not contain all the available information. It does not take the […]

APO-Amitriptyline

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-AMITRIPTYLINE TABLETS Contains the active ingredient amitriptyline (as hydrochloride) Consumer Medicine Information   What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about amitriptyline. It does not contain all the available information. […]

Rulide

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RULIDE®   Consumer Medicine Information (CMI) summary The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist.   Why am I using Rulide? Rulide contains the active ingredient […]

Tobi

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TOBI® SOLUTION FOR INHALATION Solution for Inhalation tobramycin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about TOBI Solution for Inhalation (“TOBI”). It does not contain all the available information. It does not take the place […]

Recent Posts